Ibico (Mebeverine Hydrochloride)

Mebeverine Hydrochloride works by blocking calcium entry into smooth‑muscle cells of the gastrointestinal tract. This inhibition reduces muscle contractility, easing spasms while preserving normal peristalsis, and does not act through cholinergic or serotonergic receptors.

The prescribed dose of Ibico is determined by the treating physician based on the individual’s clinical condition, severity of symptoms and response to therapy. Specific dosing regimens are not provided here and should follow the prescriber’s instructions.

Safety of Mebeverine Hydrochloride in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Ibico, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with anticholinergic agents such as hyoscine, Mebeverine (Ibico) provides smooth‑muscle relaxation without significant anticholinergic side effects like dry mouth or blurred vision. Its calcium‑channel‑blocking action offers a more targeted spasm relief while preserving normal gut motility.

Ibico should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and excessive heat to maintain its stability and potency throughout its shelf life.

Ibico is taken orally, usually with a glass of water. It may be taken with or without food, as directed by the prescribing clinician. Swallow the tablets whole; do not crush or chew unless specifically advised.

Serious but rare risks include allergic reactions such as rash, itching, swelling, or angioedema, and very uncommon cardiac arrhythmias. Patients should seek immediate medical attention if they experience any signs of severe hypersensitivity or irregular heartbeat.

Ibico should be avoided in individuals with known hypersensitivity to Mebeverine Hydrochloride or any of its excipients. Caution is also advised for patients with severe hepatic or renal impairment, and it should not be used without medical supervision in those populations.